Catalyst
Slingshot members are tracking this event:
GlycoMimetics (GLYC) and Pfizer (PFE) Initiate Phase 1 Trial Evaluating Subcutaneous Administration of Rivipansel in Vaso-Occlusive Crisis in Sickle Cell Disease
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 29, 2015
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Sickle Cell Disease, Rivipansel, Vaso-occlusive Crisis (voc), Phase 1/2
